11
CONTENTS
Title Page No.
ACKNOWLEDGEMENT 4
PARTICIPATING HOSPITALS 2011 5
STEERING COMMITTEE 2011 6
LIST OF SITE COORDINATORS 2011 7
– 9 FOREWORD
14
Report of the Malaysian National Neonatal Registry MNNR 2011 1.
ORGANIZATION OF MNNR 1.1 Objective
1.2 Structure 1.3 Funding
15 15
16
2. DATA SET
2.1 Participating Centres in 2011 2.2 Registration Criteria
2.3 Data Collection 2.4 Data Verification
16 17
17 17
3. RESULTS
Figure Table 1: Number of babies according to place of birth Figure Table 2: Frequency distribution of all babies in MNNR according to gestational
age Figure Table 3: Frequency distribution of all babies in MNNR according to birth
weight Figure Table 4: Survival to discharge of all live births admitted to MNNR hospitals
according to gestational age Figure Table 5: Survival to discharge of all babies in the MNNR according to birth
weight categories Figure Table 6: Prevalence of Patent Ductus Arteriosus PDA among all admitted
inborn in the MNNR by gestational age Figure Table 7: Prevalence of Patent Ductus Arteriosus PDA among all admitted
inborn in the MNNR by birth weight Table 8: Treatment of Patent Ductus Arteriosus PDA in admitted inborn
babies by gestational age categories Table 9: Treatment of Patent Ductus Arteriosus PDA in admitted inborn
babies by birth weight categories 19
– 20 21
– 22 23
24 25
26 27
28 28
12 Figure Table 10: Incidence of intraventricular haemorrhage IVH in admitted inborn
babies 32 weeks gestational age Figure Table 11: Incidence of intraventricular haemorrhage IVH in admitted inborn
babies
g irth eight Figure Table 12: Blood culture positive early onset sepsis in admitted inborn babies
Figure Table 13: Incidence of blood culture positive late onset sepsis in admitted inborn babies by gestational age
Figure Table 14: Incidence of blood culture positive late onset sepsis in admitted inborn babies by birth weight
Figure Table 15: Incidence of necrotizing enterocolitis NEC in admitted inborn babies according to gestational age
Figure Table 16: Incidence of necrotizing enterocolitis NEC in admitted inborn babies according to birth weight
Figure Table 17: Antenatal corticosteroid for all babies born at 32 weeks gestational age
Figure Table 18: Antenatal corticosteroid
for all a ies or at g irth eight
Figure Table 19: Incidence of retinopathy of prematurity ROP in admitted inborn babies by gestational age
Figure Table 20: Incidence of retinopathy of prematurity ROP in admitted inborn babies by birth weight
Figure Table 21: Cryotherapy laser therapy for admitted inborn babies with retinopathy of prematurity by gestational age
Figure Table 22: Cryotherapy laser therapy for admitted inborn babies with retinopathy of prematurity by birth weight
Figure Table 23: Incidence of oxygen dependency among admitted inborn babies with gestational age 32 weeks
Figure Table 24: Incidence of oxygen dependency among admitted inborn babies with
grams birth weight Table 25a : Gestational age specific mortality or significant morbidity in admitted
inborn babies five morbidities 29
30 31
32 33
34 35
36 - 38 39 - 41
42 43
44 45
46 - 47 48 - 49
50
13 Table 25b : Birth weight specific mortality or significant morbidity in admitted
inborn babies five morbidities Table 26 : Days on ventilatory support by birth weight for admitted inborn
babies discharged directly home from network hospitals Figure Table 27a: Duration of hospital stay according to gestational age in admitted
inborn babies Figure Table 27b: Duration of hospital stay according to birth weight in admitted
inborn babies 51
52 53 - 54
55 - 56
4. APPENDICES
